Edwards Lifesciences Profit Margin

The latest profit margin for EW is 15.43% as of June 2026. That compares with 72.96% in the prior-year period — down 78.8% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside Edwards Lifesciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, EW's profit margin moved from 72.96% to 15.43% — a 78.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Edwards Lifesciences's valuation or profitability profile.

Against Healthcare companies, EW currently prints 15.43% for profit margin, while the sector average sits near 15.52%. That is roughly 0.6% below the sector mean. Large gaps often invite a closer look at Edwards Lifesciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Edwards Lifesciences converts resources into returns. At 15.43%, EW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 72.96% in the prior-year period — down 78.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting EW's profit margin (15.43%), review year-over-year change from 72.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.